The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp816
TEXT MESSAGE ENGAGEMENT AND APPS FOR GI PATIENTS
Date
May 8, 2023
Explore related products in the following collection:
The landscape of digital technologies in gastroenterology is growing dramatically. However, it is difficult to identify which approaches have been effective and which ones have not achieved their promise yet. The goal of this sessions is to take a real-world approach to exploring how some examples of digital health are being used today in the field of gastroenterology, and how they can be implemented appropriately so they benefit patients and practices. This is means to be a practical guide for all types of GI clinics.
LIVE STREAM SESSION
The landscape of digital technologies in gastroenterology is growing dramatically. However, it is difficult to identify which approaches have been effective and which ones have not achieved their promise yet…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…